期刊文献+

胱抑素C与冠心病相关性的研究进展 被引量:36

Developments in Study of Relationship Between Cystatin C and Coronary Artery Disease
下载PDF
导出
摘要 既往研究已明确胱抑素C是评价肾功能损伤的一项敏感指标,然而近年的研究提示胱抑素C跟动脉粥样硬化包括冠心病以及外周动脉疾病等的发生和发展及预后密切相关,并且这种相关性反映了胱抑素C生物学的非肾性方面,其中可能通过参与炎症过程而发挥作用。 Serum concentration of cystatin C, a marker of glomerular fihration, has been associated with atherosclerosis,coronary artery disease and peripheral arterial disease, although the pathophysiology underlying this association remains unclear. At the same time, the relationship with coronary artery disease may reflect a nonrenal aspect of cystatin C biology and may produce a marked effect on the causes of inflammation in these diseases.
出处 《心血管病学进展》 CAS 2008年第1期64-67,共4页 Advances in Cardiovascular Diseases
关键词 胱抑素C 冠心病 cystatin C coronary artery disease
  • 相关文献

参考文献16

  • 1Lindholt JS, Erlandsen E J, Henneberg EW. Cystatin C deficiency is associated with the progression of small abdominal aortic aneurysms [ J ]. Br J Surg, 2001, 88 : 1472-1475.
  • 2Sukhova GK, Wang B, Libby P, et al. Cystatin C deficiency increases elastic lamina degradation and aortic dilatation in apolipoprotein E-nun mice[ J]. Circ Res, 2005,96 : 368 -375.
  • 3Yetkin E, Acikgoz N, Sivri N, et al, Increased plasma levels of cystatin C and transforming growth factor-betal in patients with coronary artery, ectasia: can there be a potential interaction between cystatin C and transforming growth factor-betal [ J ]. Coron Artery Dis ,2007,18 ( 3 ) :211-214.
  • 4Noto D,Cefalu'AB,Barbagallo CM,et al. Cystatin C levels are decreased in acute myocardial infarction:effect of cystatin C G73A gene polymorphism on plasma levels[J]. Int J Cardiol,2005,101(2) :213-217.
  • 5Luc G, Bard JM, Lesueur C. et al. Plasma cystatin-C and development of coronary heart disease : The PRIME Study [ J ]. Atheroselerosis, 2006,85 ( 2 ) : 375- 380.
  • 6Koeni W,Twardella D, Brenner H, et al. Plasma concentrations of eystatin C in patients with coronary heart disease and risk for secondary cardiovascular events: more than simply a marker of glomerular filtration rate [ J ]. Clin Chem ,2005,51 (2) :321-327.
  • 7Shlipak MG,Fried LF,Crump C,et al. Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency [ J ]. Circulation, 2003,107:87-92.
  • 8Jemberg T, Lindahl B ,Jame S, et al. Cystatin C a novel predictor of outcome in suspected or confirmed non-ST-elevation acute coronary syndrome[ J ]. Circulation,2004,110:2342-2348.
  • 9Shlipak MG,Sarnak M J, Katz R, et al. Cystatin C and the risk of death and cardiovascular events among elderly persons [ J ]. N Engl J Med, 2005,352 ( 20 ) : 2049 -2060.
  • 10Al Suwaidi J,Reddan DN,Williams K. Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes [ J]. Circulation, 2002,106:974-980.

同被引文献319

引证文献36

二级引证文献206

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部